TP53 mutated MDS and AML represent some of the most difficult diseases to treat, with poor prognosis. This webinar uses a case based approach to debate the best transplant approach (including no...
Join the ASTCT Committee on Education and Content for an engaging case discussion featuring a multidisciplinary panel, including a pediatric hematologist, radiologist, and pulmonologist. Panelists...
by Blood Advances
Researchers report that following up brexucabtagene autoleucel (brexu-cel) treatment with tyrosine kinase inhibitor (TKI)-based maintenance therapy produces a survival benefit in adults with...
by Transplantation and Cellular Therapy
New evidence upholds bendamustine as a viable alternative to fludarabine in lymphodepleting (LD) chemotherapy ahead of chimeric antigen receptor (CAR) T-cell treatment.
by Leukemia
Recent study findings may offer clues into what kind of scenarios support or undermine chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of relapsed/refractory B-cell acute...
by Immunotherapy
Injection of chimeric antigen receptor (CAR) T cells into the brain effectively treats glioblastoma multiforme (GBM), a particularly aggressive type of brain tumor, but researchers say the effect...